Table 1.

General characteristics of the different treatment groups

	Standard medical therapy (n = 6)	Molecular adsorbent recirculating system + standard medical therapy (n = 6)	Prometheus + standard medical therapy (n = 6)	P value
Age (years)	55.8 ± 1.9	54.5 ± 3.0	43.2 ± 4.7	0.097
Sex (male/female)	3/3	5/1	4/2	0.585
Serum bilirubin (mg%)	29.9 ± 4.5	25.6 ± 3.6	34.3 ± 1.9	0.245
Prothrombin time	37.6 ± 2.9	39.8 ± 4.0	40.9 ± 7.0	0.888
Albumin (g/l)	26.3 ± 1.7	27.8 ± 0.8	29.4 ± 1.7	0.348
Creatinin (mg%)	1.5 ± 0.3	1.6 ± 0.5	1.5 ± 0.2	0.984
Hepatic encephalopathy score	1 ± 0.4	1.5 ± 0.2	1.2 ± 0.4	0.473
Hepatic venous pressure gradient (mmHg)	16.8 ± 1.4	19.2 ± 1.0	15.5 ± 2.5	0.245
Child-Pugh score	13 ± 0.4	12.7 ± 0.3	11.8 ± 0.3	0.070
Sequential Organ Failure Assessment score	9.3 ± 0.9	8.3 ± 0.8	9.2 ± 0.7	0.637
Model for End-stage Liver Disease score	24.3 ± 2.4	22.7 ± 2.2	29.7 ± 1.7	0.081
Maddrey's discriminant function	70.5 ± 10.5	55.6 ± 7.3	63.2 ± 18.1	0.501

Data presented as the mean ± standard error of the mean, and represent values of the day before start of study.